[1]
Albert, A. et al. 2025. Neoadjuvant Lenvatinib in Advanced Unresectable Thyroid Carcinoma: Case Series and Literature Review. e-CliniC. 13, 1 (Jan. 2025), 6–11. DOI:https://doi.org/10.35790/ecl.v13i1.58793.